当前位置: 首页 > 期刊 > 《中国药剂学杂志》 > 2004年第3期 > 正文
编号:10783389
国外部分公司脂质体药物研发现状
http://www.100md.com
    参见附件。

     李春雷,邓英杰

    (沈阳药科大学药学院,辽宁 沈阳 110016)

    摘要:目的 介绍国外脂质体药物的开发现状。方法 综述了14家外国公司所发展的脂质体技术平台和正在开发的脂质体药物。结果和结论 目前主要有3类脂质体药物正在被开发:化疗药物\疫苗和核酸类药物。并且国外从事脂质体药物研发的公司都有自己的专利技术。

    关键词:药剂学; 研究进展;综述;脂质体

    中图分类号:R94 文献标识码:A

    Current status of liposomal drugs developed by partial foreign companies

    LI Chun-lei, DENG Ying-jie

    (School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016,China)

    Abstract: Object To review the development status of liposomal drugs in foreign companies. Method Based on information from published literatures and from internet web, the liposome technologies and liposomal drugs developed by 14 biopharmaceutical companies were introduced. Result and Conclusion It can be concluded that three kinds of liposomal drugs have been studied intensively, which include chemotherapeutic drugs, vaccines and nucleic acids that can be used for gene therapy. In addition, most of companies specializing in developing liposomal drugs possess their own proprietary technologies.

    Keywords: pharmaceutics; research progress; review; liposome

您现在查看是摘要介绍页,详见PDF附件